Although MYD88-mutated CLL cases more often had an atypical immunophenotype, the CLL cases in this study were all positive for markers characteristic for CLL including CD5, CD23, and CD200 (Table 2). Here, MYD88 is linked to B-cell chronic lymphocytic leukemia.